The Trusted Choice for the Wall Street Voice http://www.minyanville.com 2013Minyanville Publishing and Multimedia, LLC. All Rights Reserved http://www.minyanville.com/sectors/biotech-pharma/articles/Maybe-Affymax-News-Isn2527t-So-Bad/2/14/2013/id/48137 Thu, 14 Feb 2013 13:44:00EST http://www.minyanville.com/sectors/biotech-pharma/articles/Maybe-Affymax-News-Isn2527t-So-Bad/2/14/2013/id/48137 http://www.minyanville.com/sectors/biotech-pharma/articles/Pharmacyclics-Johnson-2526-Johnson-Nab-Breakthrough/2/13/2013/id/48091 Wed, 13 Feb 2013 10:03:00EST http://www.minyanville.com/sectors/biotech-pharma/articles/Pharmacyclics-Johnson-2526-Johnson-Nab-Breakthrough/2/13/2013/id/48091 http://www.minyanville.com/sectors/biotech-pharma/articles/Regeneron-Shares-Jump-as-Sanofi-Increases/2/11/2013/id/48033 Mon, 11 Feb 2013 11:38:00EST http://www.minyanville.com/sectors/biotech-pharma/articles/Regeneron-Shares-Jump-as-Sanofi-Increases/2/11/2013/id/48033 http://www.minyanville.com/sectors/biotech-pharma/articles/Six-Things-to-Watch-at-Biotech/2/11/2013/id/48025 Mon, 11 Feb 2013 09:35:00EST http://www.minyanville.com/sectors/biotech-pharma/articles/Six-Things-to-Watch-at-Biotech/2/11/2013/id/48025 http://www.minyanville.com/sectors/biotech-pharma/articles/Celgene-Gets-OK-to-Sell-Blood/2/11/2013/id/48017 Mon, 11 Feb 2013 08:05:00EST http://www.minyanville.com/sectors/biotech-pharma/articles/Celgene-Gets-OK-to-Sell-Blood/2/11/2013/id/48017 http://www.minyanville.com/sectors/biotech-pharma/articles/Biogen-Idec-Shares-Rise-on-Deal/2/6/2013/id/47931 Wed, 6 Feb 2013 11:25:00EST http://www.minyanville.com/sectors/biotech-pharma/articles/Biogen-Idec-Shares-Rise-on-Deal/2/6/2013/id/47931 http://www.minyanville.com/sectors/biotech-pharma/articles/Hemispherx2527s-Chronic-Fatigue-Drug-Rejected-by/2/5/2013/id/47889 Tue, 5 Feb 2013 09:30:00EST http://www.minyanville.com/sectors/biotech-pharma/articles/Hemispherx2527s-Chronic-Fatigue-Drug-Rejected-by/2/5/2013/id/47889 http://www.minyanville.com/sectors/biotech-pharma/articles/5-High-Profile-Drugs-Expect-FDA/1/31/2013/id/47803 Thu, 31 Jan 2013 14:45:00EST http://www.minyanville.com/sectors/biotech-pharma/articles/5-High-Profile-Drugs-Expect-FDA/1/31/2013/id/47803 http://www.minyanville.com/sectors/biotech-pharma/articles/Celsion-Shares-Nosedive-After-Cancer-Therapy/1/31/2013/id/47799 Thu, 31 Jan 2013 13:23:00EST http://www.minyanville.com/sectors/biotech-pharma/articles/Celsion-Shares-Nosedive-After-Cancer-Therapy/1/31/2013/id/47799 http://www.minyanville.com/sectors/biotech-pharma/articles/Isis-and-Sanofi2527s-Drug-OK2527d-to/1/30/2013/id/47745 Wed, 30 Jan 2013 09:15:00EST http://www.minyanville.com/sectors/biotech-pharma/articles/Isis-and-Sanofi2527s-Drug-OK2527d-to/1/30/2013/id/47745 http://www.minyanville.com/sectors/biotech-pharma/articles/Keryx-Biopharmaceuticals-Surges-on-Prospects-for/1/28/2013/id/47687 Mon, 28 Jan 2013 11:20:00EST http://www.minyanville.com/sectors/biotech-pharma/articles/Keryx-Biopharmaceuticals-Surges-on-Prospects-for/1/28/2013/id/47687 http://www.minyanville.com/sectors/biotech-pharma/articles/Threshold-Pharmaceuticals-Rises-on-Hope-for/1/25/2013/id/47651 Fri, 25 Jan 2013 12:50:00EST http://www.minyanville.com/sectors/biotech-pharma/articles/Threshold-Pharmaceuticals-Rises-on-Hope-for/1/25/2013/id/47651 http://www.minyanville.com/sectors/biotech-pharma/articles/Biogen-Idec-Aims-to-Preserve-MS/1/24/2013/id/47618 Thu, 24 Jan 2013 13:35:00EST http://www.minyanville.com/sectors/biotech-pharma/articles/Biogen-Idec-Aims-to-Preserve-MS/1/24/2013/id/47618 http://www.minyanville.com/sectors/biotech-pharma/articles/Impax-Laboratories2527-Parkinson2527s-Drug-Rejected-by/1/22/2013/id/47536 Tue, 22 Jan 2013 09:50:00EST http://www.minyanville.com/sectors/biotech-pharma/articles/Impax-Laboratories2527-Parkinson2527s-Drug-Rejected-by/1/22/2013/id/47536 http://www.minyanville.com/sectors/biotech-pharma/articles/NuPathe-Shares-Jump-After-US-Approves/1/18/2013/id/47494 Fri, 18 Jan 2013 08:57:00EST http://www.minyanville.com/sectors/biotech-pharma/articles/NuPathe-Shares-Jump-After-US-Approves/1/18/2013/id/47494 http://www.minyanville.com/sectors/consumer/articles/McDonald2527s-Chicken-Wings-Don2527t-Fly-for/1/16/2013/id/47444 Wed, 16 Jan 2013 12:10:00EST http://www.minyanville.com/sectors/consumer/articles/McDonald2527s-Chicken-Wings-Don2527t-Fly-for/1/16/2013/id/47444 http://www.minyanville.com/sectors/biotech-pharma/articles/GlaxoSmithKline-Aims-to-Compete-in-Packed/1/14/2013/id/47369 Mon, 14 Jan 2013 13:01:00EST http://www.minyanville.com/sectors/biotech-pharma/articles/GlaxoSmithKline-Aims-to-Compete-in-Packed/1/14/2013/id/47369 http://www.minyanville.com/sectors/biotech-pharma/articles/Johnson-2526-Johnson-Diabetes-Drug-Endorsed/1/11/2013/id/47321 Fri, 11 Jan 2013 08:20:00EST http://www.minyanville.com/sectors/biotech-pharma/articles/Johnson-2526-Johnson-Diabetes-Drug-Endorsed/1/11/2013/id/47321 http://www.minyanville.com/sectors/biotech-pharma/articles/Teva-Aims-to-Derail-Approval-of/1/10/2013/id/47310 Thu, 10 Jan 2013 14:16:00EST http://www.minyanville.com/sectors/biotech-pharma/articles/Teva-Aims-to-Derail-Approval-of/1/10/2013/id/47310 http://www.minyanville.com/sectors/biotech-pharma/articles/Idenix-Says-FDA-Needs-More-Time/1/9/2013/id/47278 Wed, 9 Jan 2013 13:38:00EST http://www.minyanville.com/sectors/biotech-pharma/articles/Idenix-Says-FDA-Needs-More-Time/1/9/2013/id/47278